Skip to main content
. 2022 May 26;9:925080. doi: 10.3389/fcvm.2022.925080

FIGURE 2.

FIGURE 2

ADF improved endothelium-dependent vasorelaxation without affecting endothelium-independent vasorelaxation or phenylephrine-induced vasoconstriction of small mesenteric arteries (SMA) in type 2 diabetic mice. (A) Acetylcholine (ACh)-induced endothelium-dependent vasorelaxation of SMA was impaired in Leprdb mice. Twelve weeks of ADF in Leprdb (Leprdb + ADF) restored endothelium-dependent vasorelaxation back to the level of m Leprdb control mice. (B) Incubation with the nitric oxide synthase inhibitor (L-NAME) largely attenuated ADF-induced improvement of endothelial function in diabetic mice. (C) Sodium Nitroprusside (SNP)-induced endothelium-independent vasorelaxation of SMA was comparable among groups. (D) Phenylephrine (PE)-induced vasoconstriction of SMA was comparable among groups. Data represent mean ± SEM. n = 5 mice per group with 1–2 rings per mouse. *P < 0.05 vs. m Leprdb control mice, # p < 0.05 vs. Leprdb diabetic mice.